The Observational Study of De Novo Chronic Myeloid Leukemia Patients in Chronic Phase in Japa
Not Applicable
- Conditions
- Chronic Myeloid Leukemia
- Registration Number
- JPRN-UMIN000003581
- Lead Sponsor
- The Japanese Society of Hematology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 500
Inclusion Criteria
Not provided
Exclusion Criteria
1)Patients previously treated with any investigational drug for CML. 2)Patients previously treated with IFN-alpha. 3)Patients previously receiving any oral cytotoxic drug (e.g., hydroxyurea) for at least 3 months. 4)Women with confirmed or potential pregnancy, nursing mothers, and male or female patients who wish to have a child during the study period. 5)Patients with a history of allergy to imatinib. 6)Patients with any concomitant illness that contraindicates use of imatinib. 7)Patients with any other condition that, in the investigator's opinion, disqualifies them for inclusion in the study.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method